Gangyin Xie1, Linxiao Sun1, Yonglin Li1, Bicheng Chen1, Cheng Wang1. 1. Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, Zhejiang Provincial Top Key Discipline in Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Abstract
BACKGROUND: Periplocin is a monomeric compound that exhibits anti-tumor activities. It is extracted from Cortex Periplocae. OBJECTIVE: This study aimed at determining the effect of periplocin treatment on the apoptosis and proliferation of human pancreatic cancer cells, and to elucidate on its mechanisms of action. METHODS: PANC1 and cfpac1 cells were treated with periplocin. Cell proliferation was detected by RTCA, Ki67 immunofluorescence, and a clonogenic assay. The transwell assay was used to examine cell migration and invasion functions. The expression of apoptosis-associated proteins was detected by flow cytometry and western blotting. Total RNA was extracted from the treated and untreated group of PANC1 cells for RNA-seq detection and analysis. Differentially expressed genes were screened for GO biological process and KEGG pathway analysis. Finally, CFPAC1 cells were subcutaneously inoculated into BALB / c nude mice to assess tumor growth. RESULTS: Periplocin inhibited the proliferation of PANC1 and CFPAC1 cells and induced their apoptosis by activating the AMPK/mTOR pathway and inhibiting p70 S6K. It also attenuated the cell migration, invasion, and inhibited the growth of cfpac1 xenografts in nude mice. CONCLUSIONS: Periplocin inhibits human pancreatic cancer cell proliferation and induces their apoptosis by activating the AMPK / mTOR pathway.
BACKGROUND:Periplocin is a monomeric compound that exhibits anti-tumor activities. It is extracted from Cortex Periplocae. OBJECTIVE: This study aimed at determining the effect of periplocin treatment on the apoptosis and proliferation of humanpancreatic cancer cells, and to elucidate on its mechanisms of action. METHODS:PANC1 and cfpac1 cells were treated with periplocin. Cell proliferation was detected by RTCA, Ki67 immunofluorescence, and a clonogenic assay. The transwell assay was used to examine cell migration and invasion functions. The expression of apoptosis-associated proteins was detected by flow cytometry and western blotting. Total RNA was extracted from the treated and untreated group of PANC1 cells for RNA-seq detection and analysis. Differentially expressed genes were screened for GO biological process and KEGG pathway analysis. Finally, CFPAC1 cells were subcutaneously inoculated into BALB / c nude mice to assess tumor growth. RESULTS:Periplocin inhibited the proliferation of PANC1 and CFPAC1 cells and induced their apoptosis by activating the AMPK/mTOR pathway and inhibiting p70 S6K. It also attenuated the cell migration, invasion, and inhibited the growth of cfpac1 xenografts in nude mice. CONCLUSIONS:Periplocin inhibits humanpancreatic cancer cell proliferation and induces their apoptosis by activating the AMPK / mTOR pathway.
Authors: Isadora C B Pavan; Sami Yokoo; Daniela C Granato; Letícia Meneguello; Carolina M Carnielli; Mariana R Tavares; Camila L do Amaral; Lidia B de Freitas; Adriana F Paes Leme; Augusto D Luchessi; Fernando M Simabuco Journal: Proteomics Date: 2016-09-12 Impact factor: 3.984
Authors: H Tsoi; K C Lam; Y Dong; X Zhang; C K Lee; J Zhang; S C Ng; S S M Ng; S Zheng; Y Chen; J Fang; J Yu Journal: Oncogene Date: 2017-07-10 Impact factor: 9.867
Authors: Xuejiao Liu; Mengqiu Song; Penglei Wang; Ran Zhao; Hanyong Chen; Man Zhang; Yuanyuan Shi; Kangdong Liu; Fangfang Liu; Ran Yang; Enmin Li; Ann M Bode; Zigang Dong; Mee-Hyun Lee Journal: Int J Cancer Date: 2019-04-03 Impact factor: 7.396
Authors: Josef Gillson; Yomna S Abd El-Aziz; Lionel Y W Leck; Patric J Jansson; Nick Pavlakis; Jaswinder S Samra; Anubhav Mittal; Sumit Sahni Journal: Cancers (Basel) Date: 2022-07-20 Impact factor: 6.575